Add to Your Calendar
David Barr, will serve as Co-Chair and featured speaker at PLI’s upcoming program, Developments in Pharmaceutical and Biotech Patent Law 2025, held on November 21, 2025, in New York. David will present on the session titled “Biologics, Cell and Gene Therapies: Patent Developments,” which will explore the latest legal shifts shaping some of the most dynamic areas of biopharmaceutical innovation. His presentation will provide attendees with a comprehensive understanding of case law developments relating to biologic drug products, patent challenges and opportunities in the cell and gene therapy space, recent trends in BPCIA (Biologics Price Competition and Innovation Act) litigation, major transactions and deal activity involving biologic drugs and the evolving impact of the Inflation Reduction Act on the biologics sector.